Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Anal Cancer Metastatic × reolysin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 4 Neoplasms 3 Carcinoma 3 Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Triple Negative Breast Neoplasms 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrence 1 Ras-mutated Metastatic Colorectal Cancer 1 Osteosarcoma 1 Melanoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Glioma 1 Glioblastoma 1 Fibrosarcoma 1 Anal Cancer Metastatic 1 Adenocarcinoma 1

Interventions

trifluridine tipiracil drug combination 1 reolysin 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07280377 2025-12-12

GOBLET

Oncolytics Biotech

Phase 1/2 Recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡